Archean Chemical Industries Limited has informed the Exchange about Transcript
ACI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Archean Chemical Industries reported FY25 revenue of INR1,063.45 crore with EBITDA margin of 35% and net profit of INR184.92 crore, while Q4 FY25 revenue stood at INR333.33 crore with EBITDA margin of 30.3% and net profit of ~INR58.3 crore. The company remains net debt-free with a net debt-to-equity ratio of 0.03 and announced a final dividend of INR3 per share. For FY26, management guided bromine sales volumes of 22,000-25,000 tons, industrial salt volumes of 4.5-5 million tons, and Oren Hydrocarbon revenue of ~INR150 crore. Bromine derivatives began commercial sales in Q4 with 500 tons sold, and utilization is expected to rise from 20-30% to over 50%. Management highlighted progress on strategic initiatives including the semiconductor project (awaiting central approval), Offgrid Energy Labs investment for zinc-bromide batteries, and Sulphate of Potash trials targeting H2 FY26 contribution.
The call reinforces a positive FY26 outlook with strong volume growth targets across all segments and a debt-free balance sheet supporting future investments. Shareholders may view the detailed volume guidance and diversification into derivatives, semiconductors, and energy storage as long-term growth drivers, though bromine price volatility and deferred answers on derivative realisations and capex breakdown may cap near-term upside.